http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0204148-A3
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-538 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
| filingDate | 1986-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1987-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0204148-A3 |
| titleOfInvention | [1,4]Benzodioxin and [1,4]benzoxazine derivatives |
| abstract | A compound of formula I n nin which formula nR¹ and R², which may be the same or different, each nrepresents a hydrogen atom, an alkyl group having from 1 to n4 carbon atoms or, together with the nitrogen atom to which nthey are attached, R¹ and R² form a 4 to 8-membered ring nwhich may contain an oxygen atom or another nitrogen natom, which nitrogen atom may have an alkyl group having in nfrom 1 to 4 carbon atoms as substituent. n X represents an oxygen atom or a group NR⁴ in which R⁴ nrepresents a hydrogen atom, an alkyl group having from 1 to n4 carbon atoms, a phenyl group or a phenalkyl group, the nalkyl moiety of which has from 1 to 4 carbon atoms. nan alkyl, phenyl or phenalkyl group being unsubstituted nor substituted, or nR⁴ represents a nitrogen protecting group; nm represents an integer of from 1 to 4; nn represents the integer 1 or 2; and nR³ represents a group of formula II, III, IV, V or VI n nin which formulae nR⁵ represents a hydrogen atom or an alkyl group having nfrom 1 to 4 carbon atoms; and R⁶ represents a hydrogen natom or an alkyl group having from 1 to 4 carbon atoms, an nalkenyl group having from 2 to 4 carbon atoms, or an alkynyl ngroup having 3 or 4 carbon atoms has histamine H-2 nantagonist activity, and may be used to produce medicanments. |
| priorityDate | 1985-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.